Showing results (291-300 of 565) with videos related to
Sort By:
Pageof 57
Gastroenterology|October 19, 2024
Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence SynthesisAshwin N Ananthakrishnan, M Hassan Murad, Frank I Scott, et al.Alimentary Pharmacology & Therapeutics|December 9, 2021
Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohortsKevin Casey, Emily W Lopes, Blake Niccum, et al.Journal of Crohn'S & Colitis|November 18, 2017
Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel DiseasesNienke Z Borren, Grace Conway, John J Garber, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisNeeraj Narula, Nicole H Chang, Danah Mohammad, et al.The American Journal of Gastroenterology|August 10, 2005
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trialsWilliam J Sandborn, Robert Löfberg, Brian G Feagan, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2014
Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysisAlexander C Ford, Pavit Luthra, Stephen B Hanauer, et al.Journal of Crohn'S & Colitis|April 9, 2020
Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical OutcomesBritt Christensen, Stephen B Hanauer, Peter R Gibson, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 StudyWilliam J Sandborn, Stefan Schreiber, Stephen B Hanauer, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2021
Sugars and Gastrointestinal HealthDjésia Arnone, Caroline Chabot, Anne-Charlotte Heba, et al.Inflammatory Bowel Diseases|May 23, 2009
Durability of infliximab in Crohn's disease: a single-center experienceJason E Gonzaga, Ashwin N Ananthakrishnan, Mazen Issa, et al.Pageof 57